Molecular mechanisms in enterovirus and parvovirus B19 associated myocarditis and inflammatory cardiomyopathy

被引:9
|
作者
Klingel, K [1 ]
Selinka, HC [1 ]
Sauter, M [1 ]
Bock, CT [1 ]
Szalay, G [1 ]
Kandolf, R [1 ]
机构
[1] Univ Tubingen Hosp, Dept Mol Pathol, D-72076 Tubingen, Germany
关键词
cardiotropic viruses; coxsackievirus B3; endothelial dysfunction; microcirculation; signalling pathways;
D O I
10.1016/S1520-765X(02)90104-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Enteroviruses are considered as important agents of acute and chronic myocarditis. Molecular studies in murine coxsackievirus B3 (CVB3) myocarditis have confirmed the decisive role of virus replication in initiating and maintaining cytopathic effects in myocytes, thus sustaining chronic inflammation. At the molecular level, interference with myocyte function is mediated by specific cleavage of host cell proteins by viral proteinases. There is also evidence that virus-induced activation of distinct cellular signal transduction pathways promotes enteroviral replication and myocardial dysfunction. More recently, additional viruses such as adenoviruses and, in particular, parvovirus B19 (PVB19) have been associated with inflammatory cardiomyopathy. Molecular pathology of PVB 19-associated myocarditis is characterized by infection of intracardiac endothelial cells, followed by intravascular accumulation, adhesion and penetration of inflammatory cells, resulting in endothelial dysfunction with secondary myocyte necrosis, which may clinically present with symptoms similar to that of myocardial infarction during acute infection.
引用
收藏
页码:I8 / I12
页数:5
相关论文
共 50 条
  • [41] Meningoencephalitis associated with human parvovirus B19
    Coskun, O.
    Erdem, H.
    Gul, H. C.
    Besirbellioglu, B. A.
    Sener, K.
    Eyigun, C. P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (12) : 1188 - 1190
  • [42] Arthropathy associated to parvovirus B19 infection
    Holgado, S
    Modol, JM
    Olive, A
    Tena, X
    MEDICINA CLINICA, 1996, 106 (10): : 399 - 399
  • [43] Parvovirus B19 Infection Associated with Dilated Cardiomyopathy in Patients with Previous Anthracycline Exposure
    C. J. McMahon
    H. Murchan
    T. Prendiville
    M. Burch
    Pediatric Cardiology, 2007, 28 : 394 - 395
  • [44] Parvovirus B19 infection associated with dilated cardiomyopathy in patients with previous anthracycline exposure
    McMahon, C. J.
    Murchan, H.
    Prendiville, T.
    Burch, M.
    PEDIATRIC CARDIOLOGY, 2007, 28 (05) : 394 - 395
  • [45] Outbreak of paediatric myocarditis associated with parvovirus B19 infection in Italy, January to October 2024
    Poeta, Marco
    Moracas, Cristina
    Carducci, Francesca Ippolita Cale
    Cafagno, Claudio
    Buonsenso, Danilo
    Maglione, Marco
    Sgubbi, Sofia
    Liberati, Cecilia
    Venturini, Elisabetta
    Limongelli, Giuseppe
    Nunziata, Felice
    Petrarca, Laura
    Mandato, Claudia
    Colomba, Claudia
    Guarino, Alfredo
    EUROSURVEILLANCE, 2024, 29 (48)
  • [46] B19 PARVOVIRUS
    YOUNG, NS
    BAILLIERES CLINICAL HAEMATOLOGY, 1995, 8 (01): : 25 - 56
  • [47] Parvovirus B19 Myocarditis Causes Significant Morbidity and Mortality in Children
    Molina, Kimberly M.
    Garcia, Xiomara
    Denfield, Susan W.
    Fan, Yuxin
    Morrow, William R.
    Towbin, Jeffrey A.
    Frazier, Elizabeth A.
    Nelson, David P.
    PEDIATRIC CARDIOLOGY, 2013, 34 (02) : 390 - 397
  • [48] Parvovirus B19
    Bültmann, BD
    Sotlar, K
    Klingel, K
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19): : 2006 - 2007
  • [49] Parvovirus B19
    Bundesgesundheitsblatt, 1998, 41 (2): : 83 - 87
  • [50] FATAL PARVOVIRUS B19 MYOCARDITIS IN CHILDREN AND POSSIBLE DYSIMMUNE MECHANISM
    Koehl, Berengere
    Oualha, Mehdi
    Lesage, Fabrice
    Rambaud, Caroline
    Canioni, Danielle
    Hubert, Philippe
    Leruez-Ville, Marianne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (04) : 418 - 421